Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and Monoclonal Antibodies

Alexander Wilhelm, Marek Widera, Katharina Grikscheit, Tuna Toptan, Barbara Schenk, Christiane Pallas, Melinda Metzler, Niko Kohmer, Sebastian Hoehl, Fabian A. Helfritz, Timo Wolf, Udo Goetsch, Sandra Ciesek
doi: https://doi.org/10.1101/2021.12.07.21267432

Data Availability

Sequences are available on GISAID (www.gisaid.org, access date 12/2021), under the following accession numbers. Omicron strains used in this study are as follows: B.1.1.529 (EPI_ISL_6959868; GenBank ID: OL800703), B.1.1.529 (EPI_ISL_6959871; GenBank ID: OL800702) . GenBank accession number for the SARS-CoV-2 B.1.617.2 (Delta) isolate FFM-IND5881/2021 ( GenBank ID: MZ315140).

Back to top
Posted December 11, 2021.
Download PDF
Data/Code
Email
Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and Monoclonal Antibodies
Alexander Wilhelm, Marek Widera, Katharina Grikscheit, Tuna Toptan, Barbara Schenk, Christiane Pallas, Melinda Metzler, Niko Kohmer, Sebastian Hoehl, Fabian A. Helfritz, Timo Wolf, Udo Goetsch, Sandra Ciesek
medRxiv 2021.12.07.21267432; doi: https://doi.org/10.1101/2021.12.07.21267432
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area